Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations

Abstract Since COVID-19 risk of reinfection is of great concern, the safety and efficacy of the mRNA-based vaccines in previously infected populations should be assessed. We studied 78 individuals previously infected with SARS-CoV-19, who received a single dose of BNT162b2 mRNA COVID-19 vaccine, and...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shai Efrati, Merav Catalogna, Ramzia Abu Hamad, Amir Hadanny, Adina Bar-Chaim, Patricia Benveniste-Levkovitz, Osnat Levtzion-korach
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/b7488fa59c8e41a7a74b90512388b6bf
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!